IntegriChain announces that Dave Weiss, Executive Director of Industry Solutions and industry expert on 340B analytics, will chair the 340B Track at the Medicaid Drug Rebate Program Summit (MDRP). The MDRP 340B track is slated for October 2 from 1:45 pm to 5:20 pm, and 340B sessions dominate this year’s MDRP agenda overall.
IntegriChain has tapped Gary Palgon, a 25-year life sciences and cloud-computing veteran, as Senior Vice President to lead IntegriChain’s Sales organization. Palgon was previously VP of Sales and Marketing at Liaison Technologies where he excelled at partnering with the life sciences industry in implementing enterprise-class patient and supply chain data management platforms.
IntegriChain today announced the acquisition of Medical Communication Technologies, Inc. (MCT). MCT is a top provider of government pricing and contracting software and services. IntegriChain will integrate MCT’s government pricing SaaS platform into its ICyte data platform, creating a best-in-class offering for bio/pharma manufacturers. This acquisition adds 35+ new brand and generic bio/pharma manufacturer customers to IntegriChain’s 100+ customer base and is the company’s second acquisition since entering its strategic partnership with Accel-KKR, a leading technology-focused private equity firm, in 2016.
BPO center scales bio/pharma payer analytics and contracting functions to meet today’s complex commercial and government market access challenges IntegriChain SOC compliance report available upon request Philadelphia, PA, January 29, 2018 – IntegriChain, a leading healthcare technology company delivering a comprehensive data and analytics platform covering all core elements of access—Market Access, Patient Access, and Distribution, today announced the opening of its new Access Management Operations center for claims adjudication. This new facility will house the industry’s leading contract operations offering for government and commercial rebate processing and chargeback reconciliation in Ambler, PA, a suburb of Philadelphia. Additionally, IntegriChain announced that its […]
IntegriChain announces that it has surpassed 100 bio/pharmaceutical manufacturer customers for its cloud-based platform. The Company has accelerated its customer acquisition activities, signing 19 new customers so far in 2017. To date, all top-10 and 16 of the top-20 bio/pharma manufacturers use IntegriChain solutions.
PharmaMetrics, an IntegriChain company and leading provider analytics and services to optimizing market access, today announced it has successfully completed a Service Organization Controls (SOC 1) examination of its system of controls for calculating manufacturer rebate payments.
IntegriChain launches Specialty Analytics, a cloud-based, actionable specialty patient-level insights platform. Specialty Analytics empowers market access and national account teams to optimize investments in specialty services that will help patients initiate and remain on life-changing therapies. With Specialty Analytics, brands now have the capabilities to move beyond baseline metric reporting and achieve actionable patient data insights.
IntegriChain today announced that registration is now open for its 2017 User Conference to be held October 23 to 25 in Nashville, TN. This year’s conference features a strong Executive Summit program, offering deep insights from business cases and benchmarking studies on patient and market access challenges. Additionally, the 2017 User Conference will feature manufacturer best-practice case studies as well as new industry topic tracks and hands-on training sessions.
Acquisition Strengthens IntegriChain’s Solutions Addressing Pharma’s Growing Investment in Patient Access: IntegriChain, a rapidly growing healthcare technology company, today announced the acquisition of PharmaMetrics, a leading provider of contract operations outsourcing and market access analytics software and services. The acquisition strengthens IntegriChain’s ability to deliver industry-leading analytics and contract management solutions to pharmaceutical managed markets teams to support their growing investments in patient access. This is IntegriChain's first acquisition since entering its strategic partnership with Accel-KKR, a leading technology-focused private equity firm, in 2016.
